The evolution of the TOR pathway and its role in cancer

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Oncogene

• Publication date

  2013-08-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2012.567PMID 23246968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deconvoluting the context-dependent role for autophagy in cancer

  2012cited by this paper
• Dissecting the genomic complexity underlying medulloblastoma

  2012cited by this paper
• An animal model of MYC-driven medulloblastoma.

  2012cited by this paper
• Rictor regulates cell migration by suppressing RhoGDI2

  2012cited by this paper
• BRAFV600E Negatively Regulates the AKT Pathway in Melanoma Cell Lines

  2012cited by this paper
• The crosstalk of mTOR/S6K1 and Hedgehog pathways.

  2012cited by this paper
• AMPK and mTOR in cellular energy homeostasis and drug targets.

  2012cited by this paper
• Functional Characterization of Glycine N-Methyltransferase and Its Interactive Protein DEPDC6/DEPTOR in Hepatocellular Carcinoma

  2012cited by this paper
• MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS

  2012cited by this paper
• Clonal Selection Drives Genetic Divergence of Metastatic Medulloblastoma

  2012cited by this paper
• Chronic Activation of mTOR Complex 1 Is Sufficient to Cause Hepatocellular Carcinoma in Mice

  2012cited by this paper
• Novel mutations target distinct subgroups of medulloblastoma

  2012cited by this paper
• Subgroup-specific structural variation across 1,000 medulloblastoma genomes

  2012cited by this paper
• TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.

  2012cited by this paper
• Clonal selection drives genetic divergence of metastatic medulloblastoma

  2012cited by this paper
• Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.

  2012cited by this paper
• Integrity of mTORC2 is dependent on the rictor Gly-934 site

  2012cited by this paper
• An MBoC Favorite: TOR controls translation initiation and early G1 progression in yeast

  2012cited by this paper
• mTOR signaling in growth control and disease.

  2012cited by this paper
• DEPTOR cell-autonomously promotes adipogenesis, and its expression is associated with obesity.

  2012cited by this paper
• Autophagy Suppresses RIP Kinase-Dependent Necrosis Enabling Survival to mTOR Inhibition

  2012cited by this paper
• Regulatory effects of mTORC2 complexes in type I IFN signaling and in the generation of IFN responses

  2012cited by this paper
• An overview of the mTOR pathway as a target in cancer therapy

  2012cited by this paper
• Medulloblastoma Comprises Four Distinct Molecular Variants

  2011cited by this paper
• Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney.

  2011cited by this paper
• Dual mTORC2/mTORC1 Targeting Results in Potent Suppressive Effects on Acute Myeloid Leukemia (AML) Progenitors

  2011cited by this paper
• Multiple Site Acetylation of Rictor Stimulates Mammalian Target of Rapamycin Complex 2 (mTORC2)-dependent Phosphorylation of Akt Protein*

  2011cited by this paper
• Everolimus for Advanced Pancreatic Neuroendocrine Tumors

  2011cited by this paper
• ER Stress Inhibits mTORC2 and Akt Signaling Through GSK-3β–Mediated Phosphorylation of Rictor

  2011cited by this paper
• Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy

  2011cited by this paper
• The mTOR (Mammalian Target of Rapamycin) Kinase Maintains Integrity of mTOR Complex 2*

  2011cited by this paper
• Medulloblastoma comprises four distinct molecular variants.

  2011cited by this paper
• Molecular subgroups of medulloblastoma: the current consensus

  2011cited by this paper
• The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR

  2011cited by this paper
• The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling

  2011cited by this paper
• The role of LKB1 in lung cancer

  2011cited by this paper
• Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling

  2011cited by this paper
• Overexpression of DEP domain containing mTOR-interacting protein correlates with poor prognosis in differentiated thyroid carcinoma.

  2011cited by this paper
• A Role for Autophagy in the Extension of Lifespan by Dietary Restriction in -1

  2011cited by this paper
• Emerging roles for mammalian target of rapamycin inhibitors in the treatment of solid tumors and hematological malignancies

  2011cited by this paper
• DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(βTrCP) E3 ubiquitin ligase and regulates survival and autophagy.

  2011cited by this paper
• Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size.

  2011cited by this paper
• Everolimus for advanced pancreatic neuroendocrine tumors.

  2011cited by this paper
• Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.

  2011cited by this paper
• Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling

  2011cited by this paper
• Negative Regulatory Effects of Mnk Kinases in the Generation of Chemotherapy-Induced Antileukemic Responses

  2010cited by this paper
• Sestrin as a Feedback Inhibitor of TOR That Prevents Age-Related Pathologies

  2010cited by this paper
• mTOR: from growth signal integration to cancer, diabetes and ageing

  2010cited by this paper
• Alcohol and PRAS40 knockdown decrease mTOR activity and protein synthesis via AMPK signaling and changes in mTORC1 interaction

  2010cited by this paper
• 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors.

  2010cited by this paper
• Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells

  2010cited by this paper
• Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor

  2010cited by this paper
• Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth.

  2010cited by this paper
• With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging.

  2010cited by this paper
• Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

  2010cited by this paper
• FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor.

  2010cited by this paper
• DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.

  2009cited by this paper
• Rictor/TORC2 Regulates Caenorhabditis elegans Fat Storage, Body Size, and Development through sgk-1

  2009cited by this paper
• Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1

  2009cited by this paper
• Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma.

  2009cited by this paper
• p53-dependent translational control of senescence and transformation via 4E-BPs.

  2009cited by this paper
• Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cells

  2009cited by this paper
• Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2

  2009cited by this paper
• HER2が増幅されPI3K3CAが変異した乳癌細胞におけるPI3K/mTor二重阻害剤NVP‐BEZ235による特異的アポトーシス誘発

  2009cited by this paper
• An emerging role of mTOR in lipid biosynthesis.

  2009cited by this paper
• Regulation of translation initiation in eukaryotes: mechanisms and biological targets.

  2009cited by this paper
• Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia.

  2009cited by this paper
• Amino acid regulation of TOR complex 1.

  2009cited by this paper
• Molecular mechanisms of mTOR-mediated translational control

  2009cited by this paper
• NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas

  2009cited by this paper
• mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.

  2009cited by this paper
• Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition.

  2009cited by this paper
• Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors.

  2009cited by this paper
• 4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila.

  2009cited by this paper
• An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1*

  2009cited by this paper
• Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans.

  2009cited by this paper
• Distinct clinical characteristics of Tuberous Sclerosis Complex patients with no mutation identified

  2009cited by this paper
• Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.

  2008cited by this paper
• Coordinate activation of autophagy and the proteasome pathway by FoxO transcription factor

  2008cited by this paper
• Role of the Akt pathway in mRNA translation of interferon-stimulated genes

  2008cited by this paper
• A Role for Autophagy in the Extension of Lifespan by Dietary Restriction in C. elegans

  2008cited by this paper
• TOR complex 2 is needed for cell cycle progression and anchorage-independent growth of MCF7 and PC3 tumor cells

  2008cited by this paper
• Effective Use of PI3K and MEK Inhibitors to Treat Mutant K-Ras G12D and PIK3CA H1047R Murine Lung Cancers

  2008cited by this paper
• mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).

  2008cited by this paper
• Tumorigenic activity and therapeutic inhibition of Rheb GTPase.

  2008cited by this paper
• PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo.

  2008cited by this paper
• The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1

  2008cited by this paper
• Regulation of TORC1 by Rag GTPases in nutrient response

  2008cited by this paper
• Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors.

  2008cited by this paper
• Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling

  2008cited by this paper
• Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation

  2008cited by this paper
• PTEN Loss Does Not Predict for Response to RAD001 (Everolimus) in a Glioblastoma Orthotopic Xenograft Test Panel

  2008cited by this paper
• SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs.

  2008cited by this paper
• Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.

  2008cited by this paper
• AMPK phosphorylation of raptor mediates a metabolic checkpoint.

  2008cited by this paper
• p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling.

  2008cited by this paper
• The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C

  2008cited by this paper
• The class III PI(3)K Vps34 promotes autophagy and endocytosis but not TOR signaling in Drosophila

  2008cited by this paper
• Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans

  2007cited by this paper
• The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.

  2007cited by this paper

• Development of a SIN1 targeting inhibitor as a novel therapeutic approach for the treatment of malignancies.

  2025cites this paper
• The Coordination of Pathways in Metazoans: An Integrated Framework

  2025cites this paper
• Acrylamide-mediated errors in the cell cycle regulation are associated with altered TORC2 signaling in Schizosaccharomyces pombe

  2025cites this paper
• Roles of Rictor alterations in gastrointestinal tumors (Review)

  2024cites this paper
• Hippo effector, Yorkie, is a tumor suppressor in select Drosophila squamous epithelia

  2024cites this paper
• The target of rapamycin signaling pathway regulates vegetative development, aflatoxin biosynthesis, and pathogenicity in Aspergillus flavus

  2024cites this paper
• Translation regulation in response to stress

  2024cites this paper
• TOR in plants: Multidimensional regulators of plant growth and signaling pathways.

  2024cites this paper
• Current Application of Nanoparticle Drug Delivery Systems to the Treatment of Anaplastic Thyroid Carcinomas

  2023cites this paper
• Disruption of the Keap1-mTORC2 axis by cancer-derived Keap1/mLST8 mutations leads to oncogenic mTORC2-AKT activation

  2023cites this paper
• Comprehensive Analysis of Expression and Pathway for CD27 in Esophageal Cancer

  2023cites this paper
• Propranolol, Promising Chemosensitizer and Candidate for the Combined Therapy through Disruption of Tumor Microenvironment Homeostasis by Decreasing the Level of Carbonic Anhydrase IX

  2023cites this paper
• Rapamycin supplementation of Drosophila melanogaster larvae results in less viable adults with smaller cells

  2023cites this paper
• Regulation of hematopoietic stem cells differentiation, self-renewal, and quiescence through the mTOR signaling pathway

  2023cites this paper
• Effects of Aspergillus-meal prebiotic diet on the growth performance, health status and gut microbiota of Asian seabass, Lates calcarifer.

  2023cites this paper
• Functional genome annotation and transcriptome analysis of Pseudozyma hubeiensis BOT-O, an oleaginous yeast that utilizes glucose and xylose at equal rates.

  2023cites this paper
• dMyc-dependent upregulation of CD98 amino acid transporters is required for Drosophila brain tumor growth

  2023cites this paper
• A negative feedback loop of TOR signaling balances growth and stress-response trade-offs in plants.

  2022cites this paper
• Carbon nanotube-coated recombinant human surfactant protein D reduces cell viability in an ovarian cancer cell line, SKOV3, and modulates mTOR pathway and pro-inflammatory cytokine response

  2022cites this paper
• THE EFFECT OF NUTRITION ON LONGEVITY AND FERTILITY IN DIVERSE DROSOPHILA: A TOR-MEDIATED PROCESS

  2022cites this paper
• Genes and Longevity of Lifespan

  2022cites this paper
• The use of non-model Drosophila species to study natural variation in TOR pathway signaling

  2022cites this paper
• The emerging role of NF2 alterations in new and established subtypes of renal cell carcinoma.

  2022cites this paper
• PTEN‐PI3K pathway alterations in advanced prostate cancer and clinical implications

  2022cites this paper
• Cell autonomous and non-autonomous consequences of deviations in translation machinery on organism growth and the connecting signalling pathways

  2022cites this paper
• Exogenous insulin‐like growth factor 1 attenuates cisplatin‐induced muscle atrophy in mice

  2021cites this paper
• Dual inhibition of autophagy and PI3K/mTOR pathway as a potential therapeutic strategy against laryngeal squamous cell carcinoma

  2021cites this paper
• mTOR Signaling Regulates the Development and Therapeutic Efficacy of PMN-MDSCs in Acute GVHD

  2021cites this paper
• Pongamol Inhibits Epithelial to Mesenchymal Transition Through Suppression of FAK/Akt-mTOR Signaling

  2021cites this paper
• Meiosis initiation: a story of two sexes in all creatures great and small

  2021cites this paper
• Thermal and Oxygen Flight Sensitivity in Ageing Drosophila melanogaster Flies: Links to Rapamycin-Induced Cell Size Changes

  2021cites this paper
• Biguanides drugs: Past success stories and promising future for drug discovery.

  2021cites this paper
• Tumor Growth in the High Frequency Medulloblastoma Mouse Model Ptch1+/−/Tis21KO Has a Specific Activation Signature of the PI3K/AKT/mTOR Pathway and Is Counteracted by the PI3K Inhibitor MEN1611

  2021cites this paper
• E cacy of Dual PI3K/mTOR Inhibitor Combined With Autophagy Suppression Against Laryngeal Squamous Cell Carcinoma

  2021cites this paper
• Tumor starvation by L-arginine deprivation

  2021cites this paper
• Effect of mesoporous silica nanoparticles co-loading with 17-AAG and Torin2 on anaplastic thyroid carcinoma by targeting VEGFR2

  2020cites this paper
• Preventive and (Neo)Adjuvant Therapeutic Effects of Metformin on Cancer

  2020cites this paper
• Glycosphingolipid metabolism and polycystic kidney disease.

  2020cites this paper
• Deciphering the Role of the Coagulation Cascade and Autophagy in Cancer-Related Thrombosis and Metastasis

  2020cites this paper
• Expected and paradoxical effects of obesity on cancer treatment response

  2020cites this paper
• A negative feedback loop of the TOR signaling moderates growth and enables rapid sensing of stress signals in plants

  2020cites this paper
• Torin2 inhibits the EGFR-TKI resistant Non-Small Lung Cancer cell proliferation through negative feedback regulation of Akt/mTOR signaling

  2020cites this paper
• Saccharomyces cerevisiae and Caffeine Implications on the Eukaryotic Cell

  2020cites this paper
• COVID-19 and Obesity: Dangerous Liaisons

  2020influential citation
• Mechanisms of Lifespan Regulation by Calorie Restriction and Intermittent Fasting in Model Organisms

  2020cites this paper
• Targeting the PI3K/AKT/mTOR/NFκB Axis in Ovarian Cancer

  2020cites this paper
• Silencing of microRNA-135b inhibits invasion, migration, and stemness of CD24+CD44+ pancreatic cancer stem cells through JADE-1-dependent AKT/mTOR pathway

  2020cites this paper
• mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β1–induced collagen biosynthesis

  2019cites this paper
• Identification of Novel Components of Target-of-Rapamycin Signaling Pathway by Network-Based Multi-Omics Integrative Analysis

  2019cites this paper
• Fibroblast mTOR/PPARγ/HGF axis protects against tubular cell death and acute kidney injury

  2019cites this paper
• Identification and targeting of novel CDK9 complexes in acute myeloid leukemia.

  2019cites this paper
• Nutraceuticals and "Repurposed" Drugs of Phytochemical Origin in Prevention and Interception of Chronic Degenerative Diseases and Cancer.

  2019cites this paper
• Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints.

  2019cites this paper
• TOR as a Regulatory Target in Rhipicephalus microplus Embryogenesis

  2019cites this paper
• PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics

  2019influential citation
• Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer

  2019cites this paper
• Global gene expression of histologically normal primary skin cells from BCNS subjects reveals “single-hit” effects that are influenced by rapamycin

  2019cites this paper
• AKT3 Is a Pivotal Molecule of Cadherin‐22 and GDNF Family Receptor‐α1 Signal Pathways Regulating Self‐Renewal in Female Germline Stem Cells

  2019cites this paper
• Exploring the mechanistic effects of life extending treatments on the mTOR network : a combined computational and experimental approach

  2018cites this paper
• Inhibition of mTOR/S6K1/4E-BP1 Signaling by Nutraceutical SIRT1 Modulators

  2018cites this paper
• Synergistic anti‐oomycete effect of melatonin with a biofungicide against oomycetic black shank disease

  2018cites this paper
• Systems biology approach deciphering the biochemical signaling pathway and pharmacokinetic study of PI3K/mTOR/p53-Mdm2 module involved in neoplastic transformation

  2018cites this paper
• Tumor microenvironment mediated by suppression of autophagic flux drives liver malignancy

  2018cites this paper
• Biological Aspects of mTOR in Leukemia

  2018cites this paper
• A Computational Approach to Identify Novel Potential Precursor miRNAs and their Targets from Hepatocellular Carcinoma Cells

  2018cites this paper
• Signaling Landscape of AML: The Story So Far

  2018cites this paper
• Drug Repurposing : search for a drug having effective anticancer activity

  2017influential citation
• Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia

  2017cites this paper
• Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia

  2017influential citation
• OSI‐027 modulates acute graft‐versus‐host disease after liver transplantation in a rat model

  2017cites this paper
• Central Regulatory Role for SIN1 in Interferon γ (IFNγ) Signaling and Generation of Biological Responses*

  2017cites this paper
• Molecular mechanisms controlling protein synthesis in memory reconsolidation.

  2017cites this paper
• Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways

  2017cites this paper
• Screening and purification of natural products from actinomycetes that affect the cell shape of fission yeast

  2017cites this paper
• Drug Repurposing: Targeting mTOR Inhibitors for Anticancer Activity

  2017cites this paper
• K‐Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines

  2017influential citation
• Eukaryotic translation initiation factors and cancer

  2017cites this paper
• Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma

  2017cites this paper
• Doxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells.

  2017cites this paper
• Dueling for dual inhibition: Means to enhance effectiveness of PI3K/Akt/mTOR inhibitors in AML.

  2017cites this paper
• mTOR signaling pathway is inhibited downstream of the cyclophilin D-mediated mitochondrial permeability transition in honokiol-triggered regulated necrosis.

  2016cites this paper
• tRN-A-RS Acts As Biomarker for Cancer and Other Diseases

  2016cites this paper
• Inhibition of epithelial-mesenchymal transition in bladder cancer cells via modulation of mTOR signalling

  2016cites this paper
• An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells

  2016cites this paper
• mTOR signaling in osteosarcoma: Oncogenesis and therapeutic aspects (Review).

  2016cites this paper
• Innate immune molecules in preterm birth and disease

  2016cites this paper
• Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway

  2016cites this paper
• Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo.

  2016cites this paper
• Regulation of prostate cancer cell function by activators of AMP-activated protein kinase

  2016influential citation
• The PI3K/Akt/mTOR Pathway

  2016cites this paper
• Prostate tumor attenuation in the nu/nu murine model due to anti-sarcosine antibodies in folate-targeted liposomes

  2016cites this paper
• Functional Genomics Identifies Tis21-Dependent Mechanisms and Putative Cancer Drug Targets Underlying Medulloblastoma Shh-Type Development

  2016cites this paper
• Type I Interferon-Mediated Induction of Antiviral Genes and Proteins Fails to Protect Cells from the Cytopathic Effects of Sendai Virus Infection

  2016cites this paper
• Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110α inhibition

  2016cites this paper
• Evolution of the Protein Synthesis Machinery and Its Regulation

  2016cites this paper
• Targeting the mTOR Pathway in Leukemia

  2016cites this paper
• Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer

  2016cites this paper
• Arginine dependence of tumor cells: targeting a chink in cancer’s armor

  2016cites this paper
• Evolution of TOR and Translation Control

  2016cites this paper
• UNIVERSITY OF MINNESOTA BY Jung Kim IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY Adviser

  2015cites this paper